醫療新知 > 能檢測乳癌的 itBra

能檢測乳癌的 itBra






A new technology that could revolutionize breast cancer screening is about to begin clinical trials in the Bay Area. Rather than a mammogram or ultrasound, this system can be used at home, with potentially life-saving information transmitted through a smartphone.

For Dian Gaxiola, a routine breast screening at El Camino Hospital in Mountain View turned out to be a lifesaver. Doctors caught her cancer at a very early stage and saved her breast.

"I was very lucky, I think because of the early detection," cancer survivor Dian Gaxiola said. 

El Camino Hospital Radiologist Dr. Sila Yitta says routine mammograms and self-screening are the best defense, although many women don't always take advantage. 

"In my experience it is hit or miss, I think women, some women are consistent in doing breast exams at home, some women don't do them at all, and I often times get questions from women, asking simply, 'How do I do an exam,'" Yitta said. 

However soon, an experimental technology could help thousands of women and doctors screen for breast cancer in a new way. It's called the iTBra.

"So you'll be putting that on, so it'll now be centered over you,"

Cyrcadia Health CEO Rob Royea says the patches can be worn inside any normal bra. He said, "It's a wearable device with a number of sensors that check what happens with your circadian patterns of heat change on your breast over time."

Roye says the heat changes correlate to the accelerated cell activity associated with breast tumors. The results are then processed using sophisticated algorithms and transmitted to a smartphone.

"You wear the device for a few hours, and that information is automatically communicated to your physician," Rob Royea, Cyrcadia Health

Because the system is heat based, developers believe it may also offer advantages for some women with denser breast tissue, which can be more difficult to image using traditional mammography.

"We believe we're tissue agnostic. Meaning that for all tissues we react about the same," Rob Royea from Cyrcadia Health said.

The clinical trial being conducted at El Camino Hospital will study the results on women wearing the device for different lengths of time. The goal is to produce accurate readings in roughly two hours, ultimately making the system more convenient for women to use.

"An ideal breast cancer screening test would catch the cancer when it's smaller and easier to treat," Sila Yitta, M.D., from El Camino Hospital said. 

And whether it's a routine mammogram, or at home screening, cancer survivor Dian Gaxiola believes any investment in early detection, is worth the time.

"It's very valuable," cancer survivor Fulldian Gaxioloa said. 

If the trial is successful, Cyrcadia Health hopes to have the iTBra on the market later this year.

Written and produced by Tim Didion









一家名為Cyrcadia Health的新企業就開發了名為iTbra的胸圍,它內部搭載了數個溫度探測器,並且可以配合一個程式來檢測佩戴者的乳房健康程度。該公司表示,這個產品的檢測速度比乳房X光更快,而且能夠提供更加準確的乳腺組織掃描結果。該公司CEO Rob Royea表示,截止到2016年,他們計劃在美國取得FDA認證,讓醫生用這種設備來代替傳統的乳房X光。



2022-12-15 11:00 上午 花藝班聖誕篇
2022-12-15 9:30 上午 中國傳統文化導賞團



慢性淋巴細胞白血病 (CLL) 口服標靶藥 助病人長時間穩定病情
王紹明醫生 中文大學內科及藥物治療學系名譽臨床副教授 「慢性淋巴細胞白血病 (Chronic lymphocy […]
中大全球首證血糖波動不穩的肥胖型糖尿病患者有較高患癌風險 並證實接受一類常用降血壓藥物的糖尿病患者患癌風險則較低
香港中文大學(中大)醫學院利用大數據研究糖尿病患者的患癌風險,首次獲得兩項重要發現。研究團隊發現患有糖尿病並有 […]
抗癌治療的副作用為患者帶來巨大的生理和心理壓力,肝膽胰癌症患者更經常因器官受損,比其他癌症患者較易出現相關副作 […]
中大與國際團隊領導肺癌研究 證實Lorlatinib可成為ALK陽性晚期非小細胞肺癌一線治療
香港中文大學(中大)醫學院莫樹錦教授與國際肺癌專家團隊早前針對帶有「間變性淋巴瘤激酶(ALK)基因變異」的晚期 […]
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌 2022年8月8日 1 中大醫學院領導的一項多中心臨床研究發現 […]
新藥Dostarlimab給MMR缺損病人的新希望 [醫療新資訊] MMR缺損對人們有甚麼影響呢﹖為甚麼新藥D […]
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎 ▲ 左起:病理解剖及細胞學系助理教授鄧銘 […]
芯片上的蠕蟲能視作癌症偵察器﹖ [癌症資訊新聞] 根據《科學報告》學術期刊發表了一篇研究報告指,科學家利用秀麗 […]
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者   在眾多癌 […]